BOR15001L7 / Boreaderme - LARVOL DELTA

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis (clinicaltrials.gov) - P2; N=164; Not yet recruiting; Sponsor: Laboratoire Boreaderme Inc.; Trial primary completion date: Jul 2020 ➔ Jul 2021

Clinical • Head-to-Head • Trial primary completion date